OUTCOMES OF A STANDARDIZED AYURVEDA-BASED FERTILITY PROTOCOL IN INFERTILITY: A MULTICENTER PROSPECTIVE STUDY

Background: Infertility is a growing reproductive health challenge in India, with Polycystic Ovarian Disease (PCOD), unexplained infertility, and low Anti-Müllerian Hormone (AMH) representing a significant proportion of clinical cases. This clinical study was initiated to evaluate the effectiveness of a standardized Ayurveda-based fertility protocol across multiple clinics in India. Objective: To assess conception outcomes following a structured, protocol-driven Ayurvedic fertility intervention across four primary infertility cohorts. Methods: A multicenter, prospective observational study was conducted from May 2025 onwards across India, enrolling 534 women diagnosed with PCOD (delayed and regular cycles), unexplained infertility, and low AMH. Standardized treatment protocols involving Ayurvedic formulations, ovulation tracking, male fertility support, and structured follow-up framework were implemented. The study was designed for a 90-day follow-up period; however, substantial loss to follow-up beyond 60 days resulted in primary outcome analysis based on available data during the active observation period. Results: Out of 534 enrolled patients, 167 achieved conception, resulting in an overall conception rate of 31% during the observation period. Conception rates varied across cohorts: PCOD delayed (45%), PCOD regular (27%), unexplained infertility (27%), and low AMH (33%). Patient engagement declined over time, limiting complete follow-up for a proportion of participants beyond 60 days. Conclusion: A structured Ayurveda-based fertility protocol integrated with ovulation tracking and standardized follow-up demonstrated moderate conception outcomes in real-world clinical settings. However, variability in adherence, diagnostic accuracy, and patient engagement significantly influenced outcomes. Further controlled studies are required to validate efficacy and optimize protocol adherence.

• Bala, R., Singh, V., Rajender, S., & Singh, K. (2021). Environment, lifestyle, and female infertility. Reproductive Sciences (Thousand Oaks, Calif.), 28(3): 617–638. https://doi.org/10.1007/s43032-020-00279-3
• EBSCO sign in [Internet]. Ebsco.com. [cited 2026 May 28]. Available from: https://openurl.ebsco.com/EPDB%3Agcd%3A2%3A7416706/detailv2?sid=ebsco%3Aplink%3Ascholar&id=ebsco%3Agcd%3A186266197&crl=c&link_origin=scholar.google.com
• Practice Committee of the American Society for Reproductive Medicine. Effectiveness and treatment for unexplained infertility. Fertil Steril [Internet], 2006; 86(5 Suppl 1): S111-4. Available from: http://dx.doi.org/10.1016/j.fertnstert.2006.07.1475
• Oup.com. [cited 2026 May 28]. Available from: https://academic.oup.com/jcem/article-abstract/107/6/1510/6518212
• Schenker JG, Ezra Y. Complications of assisted reproductive techniques. Fertil Steril [Internet], 1994; 61(3): 411–22. Available from: http://dx.doi.org/10.1016/s0015-0282(16)56568-6
• Apollo Fertility. How age impacts IVF success rates: key factors to know. Apollo Fertility blog. 2026 Mar 30. Available from: https://www.apollofertility.com/blog/ivf/ivf-success-rates
• InVia Fertility. Ultralow AMH levels and IVF success rates. InVia Fertility blog. 2021 Apr 13. Available from: https://www.inviafertility.com/blog/blog/infertility/drvkarande/ultralow-amh-levels-ivf-success-rates/
• Hegde Fertility. Can you think of a positive IVF pregnancy with low AMH levels? Hegde Fertility blog. 2022 Oct 16. Available from: https://hegdefertility.com/blog/can-you-think-of-a-positive-ivf-pregnancy-with-low-amh-levels/ (dapat digunakan sebagai proxy untuk data kelompok AMH rendah usia 35–40 tahun)
• Endocrinology Advisor. Low AMH levels indicate lower chance of conception. Endocrinology Advisor. 2024 Aug 4. Available from: https://www.endocrinologyadvisor.com/news/low-amh-levels-indicate-lower-chance-conception/
• Cloudnine Fertility. Natural conception with low AMH levels. Cloudnine Fertility blog. 2026 May 17. Available from: https://www.cloudninefertility.com/blog/natural-conception-with-low-amh-levels
• ColumbiaDoctors. Unexplained infertility. ColumbiaDoctors website. 2017 Jun 19. Available from: https://www.columbiadoctors.org/treatments-conditions/unexplained-infertility
•  Cites: expectant (timed intercourse) 2–4% per cycle; natural-cycle IUI ~5%; stimulated IUI (clomiphene) 5–10%; gonadotropin-IUI 7–20%.
• ESHRE (European Society of Human Reproduction and Embryology). ESHRE guideline: unexplained infertility. ESHRE website. 2023 Jan 29. Available from: https://www.eshre.eu/-/media/sitecore-files/Guidelines/UI/UI-guideline_-Final.pdf
• Zhang Y, Chen Y, Wang L, et al. Evidence-based guideline: unexplained infertility. Reprod Biol Endocrinol, 2023 Aug 20; 21(1): 105. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10546081/
• Termedia. Unexplained infertility: prevalence, possible causes and treatment options. A review of the literature. Termedia website. 2018 Mar 11. Available from: https://www.termedia.pl/Unexplained-infertility-prevalence-possible-causes-and-treatment-options-A-review-of-the-literature,113
•  Cites: average cycle fecundity in untreated group 3.8% (≈2–4%).
• ASRM (American Society for Reproductive Medicine). Evidence-based treatments for couples with unexplained infertility: a guidance document. ASRM website. 2020 Jan 31. Available from: https://www.asrm.org/practice-guidance/practice-committee-documents/evidence-based-treatments-for-couples-with-unexplained-infer
• StatPearls (NCBI Bookshelf). Female infertility. In: StatPearls. NCBI Bookshelf. 2026 Apr 11. Available from: https://www.ncbi.nlm.nih.gov/books/NBK556033/
• Journal of Neonatal Surgery. Fertility treatments and outcomes in women with PCOD. J Neonatal Surg. 2025 Jun 17. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/7465
• Raut S, Raut S. A comparative study of letrozole and clomiphene citrate for ovulation induction in women with polycystic ovarian syndrome: a randomized controlled trial. Int J Reprod Contracept Obstet Gynecol. 2024 Jul 8. Available from: https://www.ijrcog.org/index.php/ijrcog/article/view/14325 Cites: letrozole clinical pregnancy 44.8% vs. clomiphene 28.1%; live birth 36.5% vs. 22.4%
• Liu Y, Chen X, Huang Y, et al. Letrozole compared with clomiphene citrate for polycystic ovarian syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2023 Feb 28. Available from: https://pubmed.ncbi.nlm.nih.gov/36735392/ Cites: letrozole superior for ovulation (RR 1.14), clinical pregnancy (RR 1.48), live birth (RR 1.49)
• Advanced Fertility Center. Clomid for PCOS | Fertility treatment for ovulation irregularities. Advanced Fertility Center website. 2024 Sep 30. Available from: https://www.advancedfertility.com/fertility-medications/pcos-and-clomid-fertility-treatment  Cites: ~15% pregnancy per month with Clomid (3–4 months); ~50% of women who ovulate conceive
• Cochrane Database Syst Rev. Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome. Cochrane Database Syst Rev. 2016 Dec 14. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6464012/ Cites: clinical pregnancy 8–50% in clomiphene group vs. 5% placebo
• IntechOpen. Polycystic ovary syndrome phenotypes and infertility. In: Polycystic Ovary Syndrome. IntechOpen. 2022 Jan 18. Available from: https://www.intechopen.com/chapters/80036 Cites: IVF outcomes comparable to non-PCOS women (30–35% live birth per cycle)
• Indira IVF. Laparoscopic ovarian drilling in PCOS: pregnancy outcomes. Indira IVF website. 2022. Available from: https://www.indiraivf.com/blog/ivf-success-rates-by-age-and-number-of-embryos Cites: laparoscopic ovarian drilling pregnancy ~40–45% in some series